Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vitamin K | 1 | 2017 | 263 | 0.57 | Why? |
| Brain Ischemia | 5 | 2021 | 2813 | 0.50 | Why? |
| Intracranial Hemorrhages | 1 | 2017 | 1170 | 0.37 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.32 | Why? |
| Atrial Fibrillation | 2 | 2017 | 2320 | 0.30 | Why? |
| Fibrinolytic Agents | 1 | 2017 | 1702 | 0.30 | Why? |
| Stroke | 6 | 2021 | 8839 | 0.29 | Why? |
| Reflex, Pupillary | 1 | 2020 | 33 | 0.22 | Why? |
| Heart | 2 | 2020 | 1791 | 0.18 | Why? |
| Nervous System | 1 | 2020 | 303 | 0.18 | Why? |
| Contrast Media | 1 | 2021 | 1011 | 0.14 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.12 | Why? |
| Ischemic Attack, Transient | 1 | 2016 | 439 | 0.12 | Why? |
| Antibodies, Neutralizing | 5 | 2021 | 25288 | 0.12 | Why? |
| Gastrointestinal Tract | 1 | 2020 | 1113 | 0.12 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.10 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.10 | Why? |
| Kinetics | 3 | 2021 | 3238 | 0.09 | Why? |
| Critical Illness | 3 | 2021 | 17281 | 0.09 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.09 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 1510 | 0.09 | Why? |
| Thrombectomy | 1 | 2017 | 2272 | 0.08 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.07 | Why? |
| Magnetic Resonance Imaging | 1 | 2021 | 6551 | 0.07 | Why? |
| Radiography, Thoracic | 1 | 2021 | 5486 | 0.07 | Why? |
| Humans | 19 | 2021 | 930598 | 0.06 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Brain | 1 | 2016 | 5133 | 0.05 | Why? |
| Tomography, X-Ray Computed | 3 | 2021 | 25144 | 0.05 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.04 | Why? |
| Disability Evaluation | 1 | 2020 | 671 | 0.04 | Why? |
| Healthy Volunteers | 1 | 2021 | 1444 | 0.04 | Why? |
| Electrocardiography, Ambulatory | 1 | 2016 | 204 | 0.04 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Secondary Prevention | 1 | 2019 | 762 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Wales | 1 | 2016 | 758 | 0.03 | Why? |
| Virus Attachment | 1 | 2020 | 1259 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| Primary Prevention | 1 | 2019 | 778 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.02 | Why? |
| Pyrazines | 1 | 2020 | 1783 | 0.02 | Why? |
| Amides | 1 | 2020 | 1864 | 0.02 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Palliative Care | 1 | 2020 | 2665 | 0.02 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.02 | Why? |
| England | 1 | 2016 | 5116 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Adult | 4 | 2021 | 244371 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Echocardiography | 1 | 2016 | 3661 | 0.01 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Registries | 1 | 2020 | 12327 | 0.01 | Why? |
| Male | 4 | 2021 | 367725 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Female | 4 | 2021 | 380317 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Anticoagulants | 1 | 2016 | 9563 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2016 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2016 | 53120 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |